IMMP
Immutep Ltd ADR
NASDAQ: IMMP · HEALTHCARE · BIOTECHNOLOGY
$0.48
-2.01% today
Updated 2026-04-29
Market cap
$77.30M
P/E ratio
—
P/S ratio
9.76x
EPS (TTM)
$-0.41
Dividend yield
—
52W range
$0 – $3
Volume
18.7M
Immutep Ltd ADR (IMMP) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $523734.00 | — | $1.52M | $4.01M | $3.14M | $2.09M | $175052.00 | $4.22M | $2.63M | $139782.00 | $7.49M | $3.86M | $170369.00 | $3.51M | $3.84M | $5.04M |
| Revenue growth (YoY) | — | — | — | -100.0% | — | +163.5% | -21.6% | -33.3% | -91.6% | +2311.6% | -37.7% | -94.7% | +5255.8% | -48.4% | -95.6% | +1957.7% | +9.6% | +31.3% |
| Cost of revenue | — | — | — | — | $117235.00 | $939056.00 | $713311.00 | $219107.00 | $7.06M | $1.70M | $9.99M | $16.59M | $22.47M | $17.24M | $2.06M | $2.06M | $41.55M | $61.41M |
| Gross profit | — | — | $523734.00 | — | $1.40M | $3.07M | $2.43M | $1.87M | $-6.88M | $2.52M | $-7.36M | $-16.45M | $-14.99M | $-13.37M | $-1.89M | $1.44M | $-37.70M | $-56.37M |
| Gross margin | — | — | 100.0% | — | 92.3% | 76.6% | 77.3% | 89.5% | -3932.8% | 59.7% | -279.8% | -11769.3% | -200.2% | -346.2% | -1111.2% | 41.2% | -981.4% | -1117.6% |
| R&D | $330515.00 | $620028.00 | $5.12M | $9.53M | $14.50M | $14.01M | $11.93M | $8.95M | $7.06M | $7.53M | $9.99M | $16.59M | $20.40M | $17.24M | $31.34M | $28.79M | $41.55M | $61.41M |
| SG&A | $1.55M | $1.71M | $3.15M | $5.60M | $7.78M | $4.85M | $4.09M | $5.72M | $54.45M | $4.35M | $7.24M | $6.13M | $6.34M | $6.28M | $7.21M | $8.68M | $8.85M | $8.64M |
| Operating income | $-1.88M | $-2.35M | $-7.89M | $-14.13M | $-18.45M | $-15.11M | $-13.33M | $-13.92M | $-61.47M | $-9.35M | $-11.69M | $-20.42M | $-16.02M | $-31.68M | $-33.94M | $-77.69M | $-88.10M | $-126.42M |
| Operating margin | — | — | -1506.6% | — | -1213.9% | -377.1% | -424.5% | -665.3% | -35117.8% | -221.5% | -444.5% | -14606.5% | -214.0% | -820.0% | -19920.0% | -2216.0% | -2293.3% | -2506.5% |
| EBITDA | $-1.87M | $-2.75M | $-10.96M | $-14.07M | $-377299.00 | $-15.57M | $-14.00M | $-13.34M | $-61.19M | $-8.40M | $-10.38M | $-16.46M | $-11.38M | $-17.77M | $-31.87M | $-39.57M | $-44.54M | $-62.88M |
| EBITDA margin | — | — | -2092.8% | — | -24.8% | -388.6% | -446.0% | -637.4% | -34958.1% | -199.1% | -394.5% | -11778.9% | -152.0% | -460.0% | -18708.9% | -1128.8% | -1159.4% | -1246.6% |
| EBIT | $-1.92M | $-2.80M | $-11.01M | $-14.13M | $-754598.00 | $-15.82M | $-14.45M | $-14.68M | $-63.19M | $-10.11M | $-12.19M | $-18.34M | $-13.46M | $-19.66M | $-33.71M | $-41.43M | $-46.56M | $-65.01M |
| Interest expense | $0.00 | $148875.00 | $1.79M | $6.40M | $0.00 | $0.00 | $0.00 | $18.36M | $8199.00 | $0.00 | $0.00 | $0.00 | $10457.00 | $9825.00 | $92430.00 | $20401.00 | $30594.00 | — |
| Income tax | $-47196.00 | $562328.00 | $1.79M | $6.40M | — | $86873.00 | $13607.00 | $-142156.00 | $-1.18M | $-737387.00 | $1676.00 | $-2.07M | $37.00 | $33.00 | $34.00 | $2.00 | $2.00 | — |
| Effective tax rate | 2.4% | -23.6% | -17.3% | -43.6% | 0.0% | -0.6% | -0.1% | 0.4% | 1.9% | 7.3% | -0.0% | 11.3% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | 0.0% |
| Net income | $-1.89M | $-2.95M | $-12.16M | $-21.08M | $-19.94M | $-15.23M | $-13.34M | $-32.15M | $-62.02M | $-9.37M | $-12.75M | $-16.27M | $-13.47M | $-29.90M | $-32.21M | $-39.90M | $-42.72M | $-61.43M |
| Net income growth (YoY) | — | -56.1% | -312.7% | -73.4% | +5.4% | +23.6% | +12.4% | -141.0% | -92.9% | +84.9% | -36.1% | -27.7% | +17.2% | -122.0% | -7.7% | -23.9% | -7.1% | -43.8% |
| Profit margin | — | — | -2321.6% | — | -1311.9% | -380.1% | -424.9% | -1536.3% | -35426.7% | -221.9% | -484.6% | -11640.0% | -179.9% | -774.1% | -18906.5% | -1138.0% | -1111.9% | -1218.0% |